Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

431 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
New developments in the incretin concept.
Creutzfeldt W, Ebert R. Creutzfeldt W, et al. Among authors: ebert r. Diabetologia. 1985 Aug;28(8):565-73. doi: 10.1007/BF00281990. Diabetologia. 1985. PMID: 3902545 Review.
Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Nauck MA, et al. Among authors: ebert r. J Clin Endocrinol Metab. 1993 Apr;76(4):912-7. doi: 10.1210/jcem.76.4.8473405. J Clin Endocrinol Metab. 1993. PMID: 8473405 Clinical Trial.
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W. Nauck MA, et al. Among authors: ebert r. J Clin Invest. 1993 Jan;91(1):301-7. doi: 10.1172/JCI116186. J Clin Invest. 1993. PMID: 8423228 Free PMC article. Clinical Trial.
Lack of insulinotropic effect of endogenous and exogenous cholecystokinin in man.
Reimers J, Nauck M, Creutzfeldt W, Strietzel J, Ebert R, Cantor P, Hoffmann G. Reimers J, et al. Among authors: ebert r. Diabetologia. 1988 May;31(5):271-80. doi: 10.1007/BF00277407. Diabetologia. 1988. PMID: 3294066
Endocrine response to intragastric and intravenous glucose challenge in the denervated dog pancreas.
Köhler H, Schröter-Printzen I, Nustede R, Barthel M, Ebert R, Schafmayer A. Köhler H, et al. Among authors: ebert r. Int J Pancreatol. 1992 Apr;11(2):117-24. doi: 10.1007/BF02925983. Int J Pancreatol. 1992. PMID: 1607729
Lack of effect of synthetic human gastric inhibitory polypeptide and glucagon-like peptide 1 [7-36 amide] infused at near-physiological concentrations on pentagastrin-stimulated gastric acid secretion in normal human subjects.
Nauck MA, Bartels E, Orskov C, Ebert R, Creutzfeldt W. Nauck MA, et al. Among authors: ebert r. Digestion. 1992;52(3-4):214-21. doi: 10.1159/000200956. Digestion. 1992. PMID: 1459356 Clinical Trial.
Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution.
Ebert R, Creutzfeldt W. Ebert R, et al. Diabetologia. 1980 Sep;19(3):198-204. doi: 10.1007/BF00275269. Diabetologia. 1980. PMID: 6997121
Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation?
Niederau C, Berger M, Stremmel W, Starke A, Strohmeyer G, Ebert R, Siegel E, Creutzfeldt W. Niederau C, et al. Among authors: ebert r. Diabetologia. 1984 Jun;26(6):441-4. doi: 10.1007/BF00262217. Diabetologia. 1984. PMID: 6381191
Permissive effect of glucose on the glucagon-induced accumulation of cAMP in isolated rat pancreatic islets.
Schauder P, Arends J, Schindler B, Ebert R, Frerichs H. Schauder P, et al. Among authors: ebert r. Diabetologia. 1977 Apr;13(2):171-5. doi: 10.1007/BF00745146. Diabetologia. 1977. PMID: 192621
Gastric inhibitory polypeptide (GIP), gastrin and insulin: response to test meal in coeliac disease and after duodeno-pancreatectomy.
Creutzfeldt W, Ebert R, Arnold R, Freichs H, Brown JC. Creutzfeldt W, et al. Among authors: ebert r. Diabetologia. 1976 Jul;12(3):279-86. doi: 10.1007/BF00422096. Diabetologia. 1976. PMID: 955338
431 results
Jump to page
Feedback